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Abstract 
Objective- (1) To evaluate the usefulness of four leucocyte surface antigens, including 
two lymphocyte antigens (CD25 and CD45RO) and two neutrophil antigens (CDl lb 
and CD64) for diagnosing late-onset infection in preterm, very low birthweight 
infants. (2) To define the optimal cutoff values of these markers for diagnosing late-
onset infection. (3) To investigate the plasma levels of proinflammatory and anti-
inflammatory cytokines in non-infected preterm, very low birthweight infants and 
compare them with infected preterm infants. 
Method- Very low birthweight infants in whom clinical sepsis was suspected when 
they were >72 hours of age were recruited into the study. A full sepsis screen was 
performed in each episode. Seven cytokines markers of the proinflammatory and anti-
inflammatory pathways, including interleukin (IL) 2, lL-4, IL-5, IL-6, IL-10, 
interferon-gamma (IFN-y) and tumour necrosis factors (TNF-a) and four leukocyte 
viii 
Abstract 
surface antigens were measured at time 0 hour (at the time of sepsis evaluation), 24 
hours and 48 hours. All cytokine levels, except IL-6, were quantified by the flow 
cytometry method - Cytometric Beads Array assay. Enzyme linked immunoassay was 
used to measure the plasma level of IL-6. The leukocyte surface antigens were 
quantified by flow cytometry QuaiitiBRITE beads assay and expressed as the antigen 
binding sites per cell (ABC). 
Results- One hundred twenty-seven episodes of suspected clinical sepsis were 
investigated in 80 infants. Thirty-seven episodes were proven infection or necrotising 
enterocolitis. The calculated optimal cutoff values for lymphocyte surface antigens 
(CD25 and CD45RO) and the neutrophil surface antigens (CDl ib and CD64) were 
3,100, 2,900 10,450 and 4,000 respectively. After an interim analysis of 68 episodes, 
two lymphocytes antigens were excluded from the study because both CD25 and 
CD45RO were considered to be poor predictors of neonatal infection with sensitivity 
or specificity <75%. On the contrary, CD64 has the highest sensitivity (95%-97%) 
and negative predictive value (97%-99%) at time 0 and 24 hours. The combined 
analysis of CD64 (at 24 hours) with IL-6 or C-reactive protein (at time 0) further 
enhanced the sensitivity and negative predictive value of CD64 to 100%. The 
specificity and positive predictive values were 88% and 80%, respectively. 
viii 
Abstract 
For the cytokine study, both proinflammatory (IL-2, IL-6, IFN-y, TNF-a) and anti-
inflammatory (IL4, IL-10) cytokines were significantly increased in the infected 
group compared with the non-infected and control groups. Significant correlation was 
observed between IL-6, IL-10 and TNF-a as well as IL-10 and IFN-y. The ratio of 
IL-10/TNF-a and IL-6/IL-10 were significantly increased in patients with 
disseminated intravascular coagulation compared with infected infants without the 
condition. 
Condusion-Our results show that neutrophil CD64 expression is a very sensitive 
marker for diagnosing late-onset infection in preterm, very low birthweight infants 
and could be used for early discontinuation of antibiotic treatment in non-infected 
patients. Cytokines IL-6, IL-10 and TNF-a as well as the IL-lO/TNF-a and IL-6/IL-
10 ratio are significantly increased in infected infants. This study also suggests that 
the regulatory mechanism between the proinflammatory and anti-inflammatory 
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胞儀的C y t o m e t r i c Beads Array A s s a y法測定°血清白細胞介素 - 6的 
水平用酶聯免疫法測得。白細胞表面抗原用流式細胞儀的 
QuantiBRITE Beads Assay法測定，並用每個細胞表面的抗原結合點 
的數目來表示。 
硏究結果 
共有8 0個病人� 1 2 7人次的臨床疑似敗血症被硏究。其中3 7 
人次被證實爲細菌感染或壞死性的小腸結腸炎°淋巴細胞表面抗原 
( C D 2 5 � C D 4 5 R O ) 和中性粒細胞表面抗原（ C D l l b � C D 6 4 ) 的最 
佳診斷値分別爲： 3 1 0 0 � 2 9 0 0 � 1 0 4 5 0 和 4 0 0 0 °經過對 6 8人次的初 
步分析’淋巴細胞表面抗原C D 2 5和C D 4 5 R O的靈敏度或特異性 
<75%，我們認爲其對診斷新生兒感染沒有幫助，從而終止了對它們 
的硏究。我們的硏究發現：CD64在第0小時和第24小時具有最高 
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Chapter 1: Introduction and Objectives 
1.1 Neonatal sepsis 
The incidence of neonatal sepsis is reported to range from 1 to 8 cases per 1000 
live births, with the highest rates being reported in low birth weight preterm infants 
(Stoll BJ 1996). The frequency of infection increases with decreasing gestational age, 
rising from 0.6% in term infants to 16.6% in infants of less than 28 weeks gestation 
(Seo K 1992). The development of sepsis in neonates can be separated into two 
distinct clinical phases: early onset (within 72 hours of birth) and late onset (after 72 
hours of age). 
Late-onset nosocomial bacterial infection is an important cause of morbidity and 
mortality in newborn infants requiring intensive care (Stoll BJ 1996). Preterm, very 
low birthweight (VLBW) infants whose body weights are less than 1500 g, are 
particularly vulnerable because of immune immaturity, severe underlying conditions 
and frequent requirement of invasive procedures such as arterial or venous umbilical 
catheterisation, central venous line placement and insertion of chest drains. It has 
been estimated that up to 25% of VLBW infants will develop one or more episodes of 
culture-proven sepsis that are caused by nosocomial infection during their stay in 
neonatal intensive care (Stoll BJ 1996). The vast majority of these infections are 
caused by Gram positive bacteria, with coagulase-negative staphylococci being the 
- 2 
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dominant organism (Stoll BJ 1996). Gram negative organisms {Klebsiella sp, E Coli), 
fungi {Candida sp, Malassezia sp), and viruses (herpes, respiratory syncytial virus) 
can also cause late-onset infections. Fungal infections occur in 2% to 5% of premature 
infants, especially if the infants receive prolonged hyperalimentation through central 
venous catheters (Broviac catheters are more likely to become colonized and infected 
than percutaneous silastic catheters) or if they received multiple courses of 
broad-spectrum antibiotics (Johnson DE 1984, Jacobs RF 1990). Infected infants must, 
therefore, be promptly identified and differentiated from non-infected patients, and 
antibiotics commenced without delay. However, as results of microbiological 
culture and antimicrobial susceptibility data are not usually available until at least 48 
hours after the specimen reaches the laboratory, early identification of genuine sepsis 
is recognised to be a major diagnostic problem. In addition, antimicrobial therapy 
based solely on risk factors and clinical grounds is likely to result in over-treatment. 
Continuation of antibiotics for presumptive bacterial infection frequently leads to 
unnecessary and prolonged therapy. Thus, a reliable infection marker or a set of 
markers are required to promptly and accurately identify the infected cases so that 
treatment can be started without delay, and cases subsequently identified not to be 
sepsis should have anti-microbial therapy stopped as soon as possible. 
- — ^ -
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1.2 Markers of Infection 
In the past decades, many investigators have used various haematological and 
biochemical markers, and cytokines including immature/total neutrophil ratio 
(Rodwell RL 1988，Berger C 1995), C-reactive protein (CRP) (Franz AR 1999, 
Hatherill Ml999)，procalcitonin (Gendrel D 1996, Assicot M 1993), tumour necrosis 
factor alpha (TNF-a) (Ng PC 1997, Messer J 1996), interleukin ( IL) - lp (Ng PC 1997), 
soluble Interleukin - receptor antagonist (IL-lra ) (Kiister H 1998), IL-2 receptor 
(Jurges ES 1996), IL-6 (Buck C 1994, Ng PC 1997, Kiister H 1998), IL-8 (Franz AR 
1999; Berner R 2000), lL-10 (van der Poll T 1997) and markers of 
complement-activation (Zilow G 1993, Guillois B 1994) as indicators for early 
diagnosis of neonatal infection. To date, there has not been a single marker or a 
combination of infection markers that could unequivocally diagnose neonatal sepsis. 
Our series of studies, therefore, aimed to identify a better infection marker or a 
combination of markers that could assist clinicians in stopping the use of unnecessary 
antibiotic treatment in non-infected patients. 
1.2-1 Clinical markers for sepsis 
CRP was discovered in 1930 by Tillett et al (Tillet WS 1930) in their studies of 
serological reactions that accompanied pneumonia. It is an acute phase protein. The 
-
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term "acute phase" was introduced in reference to acutely ill patients with infections 
whose sera contained the C-reactive component (Macleod CM 1941). CRP (molecular 
mass 106 kDa) consists of five noncovalently-bound, identical subunits, each 
containing 187 amino acids, with one intra-chain disulfide bond and no carbohydrate 
modifications (Gewurz H 1995, Nudelman R 1983，Pepys MB 1981). It is synthesized 
within 6-8 hours of exposure to an infective process or tissue damage, and it has a 
half-life of about 19 hours. CRP may be increased over a thousand fold during an 
acute phase response (Vigushin D 1993). 
CRP activates the classical pathway of complement which is one of its main 
mechanisms in providing host defense. CRP interacts with the cells of the immune 
system by binding to Fc gamma receptors (FcyRl), (Figure 1.1) and is an important 
component of the innate immune system. It may thus bridge the gap between innate 
and adaptive immunity, and provide an early and effective anti-bacterial response (Du 
Clos 2002). 
CRP is one of the common clinical infection markers used for the identification 
of neonatal sepsis (Forest JC 1986, Ainbender E 1982, Claudio C 2003). The result of 
CRP can be made available within a few hours of blood collection and it has relatively 
i 
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high sensitivity (76%) and specificity (79%) for diagnosing bacterial infection (V 
Manucha 2002). 
The other routine clinical markers of neonatal sepsis such as total leucocyte 
count (TLC), total neutrophil count (TNC), immature to total neutrophil (I/T) ratio, 
immature to mature neutrophil count (I/M) ratio, morphological or degenerative 
changes in neutrophils including vacuolisation, Dohle bodies, intracellular bacteria, 
toxic granulation, and platelet count, have been studied either singly or in 
combination (Rodwell RL 1988). However, the diagnostic utilities of white cell 
counts and ratios varied widely across studies, with sensitivity and specificity ranging 
from 17-90% and 31-100% respectively (Da Silva O 1995). Manroe et al observed an 
I/T ratio of 0.16 in healthy neonate in the first 24 hours of life, which then fell to 0.13 
by 60 hours and remained at that level until 28 days of age (Manroe BL 1979). Engle 
and Rosenfeld observed that I/T and I/M ratios (46% and 61%, respectively) were 
abnormal in a group of neonates with sepsis compared to those with maternal sepsis 
only (4% and 12%) and neonates with asphyxia (13% and 22%) (Engle WD 1984). In 
general, the abnormal leucocyte ratios, I/T ratio > 0.2, tend to have high sensitivity, 
whereas abnormal leucocyte counts, such as leucopenia and neutropenia, carried a 
high specificity for diagnosis of neonatal sepsis (Berger C 1995, Da Silva O 1995， 
i 
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Rodwell RL 1988). 
1.2-2 Cytokines as markers of sepsis 
During infection, the host produces proinflammatory and anti-inflammatory 
cytokines that have been implicated as playing crucial roles in the pathogenesis of the 
inflammation and infection (Figure 1.2). Human cytokines, such as, TNF-a, IL-6 and 
IL-8 have been considered as early potential markers of infection in newborn infants 
(D0llner H 2001, Nupponen 1 2001, Franz AR 1999，Buck C 1994). TNF-a is a 
principle initiator of systemic inflammation, rising early in human models of 
endotoxaemia (Hack CE 1997), and together with IL-6 up-regulates CRP production 
(Moshage H 1997). Elevated circulating TNF-a and IL-6 levels might therefore be 
detectable before any measurable increase in the CRP. IL-6 was found to be more 
sensitive than CRP, IL-lp and TNF-a for the early diagnosis of neonatal bacterial 
infection at the onset of illness (Ng PC 1997). However, it has a very short half-life, 
and the levels fall precipitously with treatment and become undetectable in the 
majority of infected patients within 24 hours (Ng PC 1997, Buck C 1994). Gonzalez 
et al demonstrated that the serum IL-6 levels at day 0 and day 1 of presentation were 
significantly higher in infants with confirmed sepsis, before blood culture results 
became available (Gonzalez BE 2003). Martin et al also showed that newborn infants 
-
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with septicemia have increased reactive hyperaemia and elevated cytokine IL6, IL-8 
and TNF-a very early in their illness (Martin H 2001). IL-8 is also considered to be a 
highly accurate marker with sensitivities ranging from 80%-91% and specificities 
ranging from 76%-100% (Franz AR 1999, 2001; Bemer R 2000, Nupponen I 2001). 
The diagnostic accuracy is further enhanced by the simultaneous measurement of 
either CRP (Franz AR 1999, 2001) or neutrophil cell surface marker CDl lb 
(Nupponen 1 2001). The combination of IL-8 and CRP has also been suggested to be 
useful in reducing unnecessary antibiotic usage (Franz AR 1999, 2001). 
1.2-3 Cell surface receptors as markers of sepsis 
Beside cytokines, specific leucocyte surface antigens were either up-regulated or 
down-regulated after these inflammatory cells were activated by bacteria or their 
cellular products (Lehr HA 1995, Simms HH 1995). The circulating levels of 
cytokines might not respond early enough to the occurrence of sepsis at the onset of 
disease. Therefore, cell surface markers could be used to identify very early 
immunological response to bacterial infection. 
For diagnosis of neonatal infection, several activation markers have been 
investigated. Recently, Hodege G et al have shown that the combination of CD45RA, 
-
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CD45RO, CD25 and CD69 expression on peripheral blood-derived T cells was a 
sensitive and specific combination of cell surface antigens for diagnosis of neonatal 
infection. CD69 was up-regulated on NK cells in 13 out of 16 proven sepsis, and 
CD69 appeared to be the most sensitive marker among the four being studied 
(Hodege G 2004). Neutrophil C D l l b was also extensively studied for early onset 
neonatal infections (Nupponen I 2001 Weinschenk NP 2000, Weirich E 1998). It is 
normally expressed at a very low level on the surface of nonactivated neutrophils 
(Weirich E 1998). However, C D l l b expression increases markedly within a few 
minutes after the inflammatory cells come into contact with bacteria and endotoxins 
(Lehr HA 1995, Simms HH 1995). This unique characteristics enable C D l l b to be 
used as a potential early warning marker for prediction of bacterial infection (Santana 
C 2001, Weirich E 1998). C D l l b has high sensitivity (96%-100%) and specificity 
(100%). In addition, neutrophil CD64 has been reported to be a highly effective 
marker for the diagnosis of late-onset infection (Ng PC 2002, Fjaertoft G 1999). 
CD64 is the high affinity Fcy-receptors (FcyRl) that is normally express in a very low 
level by neutrophils. Fc receptors on white blood cells are important for effective 
phagocytosis of bacteria and are up-regulated during infection (de Haas M 1995, 
Sanchez-Mejorada G 1998). Fjaertoft et al reported that neutrophils from newborn 
infants with bacterial, infections expressed FcyRI in significantly higher levels, 
-
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compared with those in non-infected preterm or term newborn infants (Fjaertoft G 
1999). They also demonstrated that neutrophils from preterm neonates expressed 
FcyRI to the same extent as neutrophils from term neonates, older infants , children, 
and adults (Fjaertoft G 1999). Another activation surface marker, T cell CD45RO, 
was studied for its ability to diagnose prenatal and postnatal infections in newborns 
and fetuses (Bruning T 1997). Healthy newborns who have not experienced infection 
express CD45RO on a minority of the T cell population. CD45RO cells are derived 
from naive CD45RA+ T cells upon antigenic or mitogenic stimulation (Vitetta ES 
1991). Weinschenk et al observed that the expression of CD66b and CD33 on 
neutrophils was significantly elevated in infants with sepsis but CD33 was expressed 
on peripheral monocytes and only weakly on granulocytes. CD33 is a marker of cell 
activation but its function is unclear (Weinschenk NP 2000). In contrast to the 
up-regulation of these markers upon infection, the expression of HLA-DR on 
monocytes was decreased in adult septic patients after trauma or surgery compared 
with non-septic patients. (Ditschkowski M 1999’ Wakefield CH 1993). 
1.3 The immune system in response to pathogen challenge 
Figure 1.2 is a schematic diagram showing the recognition of pathogens and 
other forms of antigenic materials by blood cells that results in the activation of T 
-
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helper cells (ThO). This process involves adaptive events occurring within and on the 
surface of specialised antigen-presenting cells (APC) working in concert with the 
innate response of local cells and tissues to the presence of foreign materials. The 
latter includes the production of cytokines that steer the differentiation of T helper 
cells into the Thl or Th2 subsets. In particular, IL-4 is essential for the development 
of a Th2 response and IL-12 is important for a Thl response. These cytokines then 
bind to the activated T cell receptors and initiate the differentiation of other cells of 
the immune system to produce cytotoxins and release cytokines (cytotoxic T cells, 
macrophages) or immunoglobulins (plasma cells), thus mediating defense response 
against the antigen-bearing pathogen. Besides activation of T cells differentiation, a 
cross-regulation effect also interacts between the Thl and Th2 subsets. For instance, 
IFN-y (secreted by Thl subset) preferentially inhibits proliferation of the Th2 subset, 
and IL-10 (secreted by the Th2 subset) down-regulates the secretion of IL-12 (Gordon 
Reeves, Lecture notes on Immunology 2000). 
1.3-1 Source of cytokines 
Cytokines were originally described as extracellular protein messenger 
molecules produced by cells involved in essentially all biological processes, such as 
in cell growth, differentiation, inflammation, immunity, repair, and fibrosis. However, 
-
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the molecular characterization of these proteins has revealed that many (e.g. TNFa, 
IL- la , TGF) function as cell surface signaling molecules (Kriegler M 1988). Their 
roles in these processes are diverse, in some instances being pathogenic, in others 
being protective and most of the time, being innocent bystanders. (Oppenheim JJ 
Clinical Applications of Cytokines, 1993). A key feature of cytokines is their 
'potency' - meaning that they are bioactive at very low concentrations, often in the 
range of 10"'"to 10"'^  mol/L. This potency is linked to the affinity for their receptors. 
Signaling does not require high receptor occupancy and often 10% occupancy will be 
sufficient for initiating an inflammatory response (Jan Vilcek The Cytokine Handbook 
1998). Essentially, all cells synthesize cytokines when stimulated. Macrophages, T 
cells and mast cells are among the most abundant sources, but other cells of the 
haematopoietic linage such as B cells, dendritic cells, and natural killer (NK) cells are 
also important sources, as are nonhematopoietic cells such as fibroblasts, 
chondrocytes, hepatocytes, epithelial cells (Jan Vilcek The Cytokine Handbook 1998). 
1.4 General outline of cytokines implicated in sepsis 
Cytokines are important molecules in the induction and resolution of 
inflammatory responses. There are many 'proinflammatory cytokines', but 
considerably fewer 'anti-inflammatory cytokines'. The classical proinflammatory 
-
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cytokines include IL-1, IL-2, IL-6, IL-12, GM-CSF, TNF-a and IFN-y. These 
molecules can induce both acute and chronic inflammatory responses. The 
anti-inflammatory cytokines include lL-4 and IL-10 (Figure 1.2). Cytokines are 
involved in innate immunity with chemokines such as IL-8 that participates in the 
recruitment and activation of neutrophils. Chemokines are also major contributors to 
inflammation, being involved in the chemotaxis of neutrophils and subsequently 
macrophages, lymphocytes and eosinophils to the site of inflammation (Oppenheim JJ 
Clinical Applications of Cytokines, 1993). 
The following section will describe the characteristics of the 7 cytokines that 
were studied in this project. 
1.4-1 Interleukin 2 (IL-2) 
lL-2 is an autocrine and paracrine growth factor secreted by activated T 
lymphocytes. It is essential for T cell proliferation. The IL-2 molecule was first 
identified and characterized as a growth factor for CD8+ T cell clones, which were 
derived from long-term IL-2-dependent cytolytic T lymphocyte lines (Baker PE 1979, 
Gillis S 1978, Gills S and Smith KA 1977). Although IL-2 also serves as a growth 
factor for CD4+ T cells (Giillberg M and Smith KA 1986), as well as NK cells 
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(Caligiuri MA 1990)，the expansion of cytolytic T lymphocytes (CTL) is undoubtedly 
one of its most important functions within the host defense system. 
The differentiation of both Th cells and CTL is influenced by IL-2. IL-2 is 
obligatory for the generation of both Thl and Th2 cells, and it potentiates the 
production of the characteristic cytokines released by these differentiated Th cells 
(Seder 1994 RA, Seder and Paul WE 1994, Swain SL 1994). In a similar fashion, the 
production of cytokine by CTL, particularly IFN-y and TNF-a, is markedly 
augmented by IL-2. IL-2 also promotes CTL activity by activating the expression of 
the cytolytic molecules, such as perforin and the serine esterases found in the cytolytic 
granules of CTL (Goldsmith, M.A. The Cytokine Handbook 1994). 
The biological effect of IL-2 is mediated by the specific cell surface receptor 
complexes. The functional high-affinity receptor for IL-2 is composed of three 
distinct polypeptide chains, the IL-2 receptor a , p, and 
y subunits (Minami, Y 1993, Sugamura K 1995). The intermediate-affinity IL-2 
receptor complex, which lacks the a subunit but contains both the p and y subunits, is 
capable of transducing the IL-2 signal (Cantrell and Smith 1983, 1984). Santana et al 
showed that the soluble IL-2 receptor was significantly increased in infected neonates. 
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As a marker in combination of CRP and IL-8, it provided high sensitivity and 
specificity (Santana R 2003). IL-2 also acts a cofactor with IFN-y for the induction of 
activated macrophage in the resistance to infection (Belosevic M 1990). 
1.4-2 Interleukin 4 (IL-4) 
IL-4 is a pleiotropic cytokine produced primarily by activated T lymphocytes, 
mast cells and basophils (Howard M Guidebook to Cytokines and their Receptors 
1994). It elicits many biological responses, and two stand out as being of clinical 
importance: the regulation of helper T cell differentiation in the Th2 type, and 
stimulation of IgE antibodies production via the differentiation of B cells into 
IgE-secreting cells (Brown MA 1997, Wang P 1995). 
IL-4 has marked inhibitory effects on the expression and release of 
proinflammatory cytokines. It is able to block or suppress the monocyte-derived 
cytokines, including IL-1, TNF-a, IL-6, IL-8, and macrophage inflammatory protein 
(MlP)- la (Brown MA 1997, Wang P 1995，Paul WE 1991). It has also been shown to 
suppress macrophage cytotoxic activity, parasite killing, and macrphage-derived nitric 
oxide production (Vannier El992). In addition to its inhibitory effects on the 
production of proinflammatory cytokines, it stimulates the synthesis of the cytokine 
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inhibitor IL-lra (Hart PH 1989). 
1.4-3 Interleukin 5 (IL-5) 
lL-5 is a member of the cytokine family of polypeptides and glycoproteins that 
regulates cellular and humoral immune responses. The human IL-5 gene is located on 
chromosome 5 (Sutherland GR 1988). It is produced mainly in T cells in response to 
stimulation by parasite-derived antigens and allergens. In addition, various 
transformed B-cells, Reed-Sternberg cells in Hodgkin's disease and activated 
eosinophils can express IL-5 mRNA. (Mckenzie NJ 1992) 
The eosinophilopoietic action of IL-5 was first demonstrated in mouse bone 
marrow cultures and was found to be cell-lineage specific (Sanderson, CJ 1985). The 
production of eosinophils in this system is markedly enhanced in parasite-infected 
mice. The administration of anti-IL-5 in vivo to parasitized mice completely abolishes 
the eosinophilia, suggesting that IL-5 is the main factor responsible for eosinophilia in 
this model (Rennick DM 1990). The effect of IL-5 on human eosinophils is very 
similar to that seen in mice. Among the pathogens that cause infection, only the 
helminthes parasites elicit the lL-5-mediated processes (e.g. eosinophilia), and an 
expansion of lL5-producing cells is an almost universal consequence of human 
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helminth infection (Medhat A 1998). 
The understanding of the biological role of IL-5 in the regulation of eosinophilia 
and the development of immunity to parasites will be critical for application of 
immunotherapy with IL-5 or inhibition of its activity in infectious, neoplastic, and 
other diseases. 
1.4-4 Interleukin 6 (IL-6) 
IL-6 is a pleiotropic cytokine that plays a central role in the inflammatory 
cytokine cascade for maintaining homeostasis (Kishimoto T 1992). Its activities 
include synergizing with lL-1 and TNF to stimulate immune responses (Libert C 1994, 
Xing Z 1998); inducing the acute-phase response in liver cells; enhancing B cell 
replication, differentiation, and immunoglobulin production; stimulating 
hematopoiesis and thrombopoiesis; and supporting the growth of transformed 
hepatocyte and myeloma cell lines in tissue culture. 
The gene for lL-6 is located on human chromosome 7. The reported molecular 
weight (MW) of IL-6 ranges between 22,000 and 30,000, owing to variations in the 
degree of glycoslyation and phosphorylation of the polypeptide. IL-6 can be produced 
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by many cell types, including activated T and B lymphocytes, monocytes, endothelial 
cells epithelial cells, and fibroblasts (Van Snick 1990). 
IL-6 plays a key role in immunological response to challenges on body 
homeostasis (Hirano T 1990). It enhances IL-2 and IFN-y induction of differentiation 
of cytotoxic T cells. IL-6 is a hematopoietic growth factor and contributes to bone 
remodeling and induces neuronal cell differentiation (Barton BE 1997). The 
concentration of IL-6 in serum is elevated during general trauma, endotoxemia, acute 
or chronic inflammation, infectious or metastatic diseases, or by nearly any challenge 
that triggers a host defense response (Sakamoto K 1994). 
1.4-5 Interleukin 10 (IL-10) 
IL-10 is a very important anti-inflammatory cytokine found within the human 
inflammatory cascade. It is a potent inhibitor of Thl cytokines, including both IL-2 
and IFN-y. This activity accounts for its initial designation as a cytokine synthesis 
inhibition factor (Lalani I 1997, Howard M 1992, Opal SM 1998). In addition to its 
activity as a Th2 lymphocyte cytokine, IL-10 is a potent deactivator of 
monocyte/macrophage proinflammatory cytokine synthesis (Brandtzaeg P 1996, 
Clarke CJP 1998). IL-10 is primarily synthesized by CD4+ Th2 cells, monocytes and 
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B cells, and it circulates as a homodimer consisting of two tightly packed 
160-amino-acid proteins (Howard M 1992, Opal SM 1998). After engaging its 
high-affinity 110-kd cellular receptor, IL-10 inhibits monocyte/macrophage-derived 
TNF-a, lL-1, IL-6, IL-8, IL-12, granulocyte colony-stimulating factor, MlP-a, and 
MlP-2a (Clarke CJP 1998, Gerard D 1993, Marchant A 1994). IL-10 inhibits cell 
surface expression of major histocompatibility complex class II molecules and B7 
accessory molecule CD 14 (Opal SM 1998). It also inhibits cytokine production by 
neutrophils and natural killer cells. 
A number of infectious diseases are characterized by a lack of cell-mediated 
immunity and hypo-responsiveness to the inducing pathogen. The involvement of 
IL-10 in infections is revealed by the enhanced production of this cytokine by 
patients' peripheral blood mononuclear cells (PBMC), and the restoration of 
antigen-specific proliferative responses of patients' PBMC in vitro by the neutralizing 
antibodies against IL-10 (Sieling 1993, Peyron 1994, Mahanty 1996). 
1.4-6 Interferon gamma (IFN-y) 
Human IFN-y is a multifunctional protein first observed as possessing antiviral 
activity in culture of Sindbis virus-infected human leukocytes stimulated by 
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phythaemaglutine (PHA) (Wheelock EF 1965). Produced by T lymphocytes and NK 
cells, IFN-y is known to be an inhibitor of viral replication and a potent regulator of 
immunological function. There is only a single active form of IFN-y protein — a 
homodimer of MW 18,000 polypeptides that can be glycoslyated to various degrees. 
I F N - Y influences the class of antibody produced by B cells. It up-regulates class I and 
II MHC complex antigens and increases the efficiency of marcophage-mediated 
killing of intracellular parasites (Ijzermans JM 1989, Mogensen SC 1987). IFN-y is 
also the most potent known activator of macrophages. Exposure to IFN-y greatly 
enhances the microbicidal activity of macrophages and induces them to secrete 
monokines such as IL-1, IL-6, IL-8, and TNF-a (Tristram GP Medical Immunology 
2001). 
IFN-y may play a role in the differentiation of T cells into populations with a Thl 
or Th2 cytokine production profile. The cytokines with the highest impact on this 
differentiation are IL-12 and IL-4. IL-12 is a strong inducer of IFN-y and a promoter 
of the Th 1 track. Conversely, IL-4 is an antagonist of IFN-y and a strong promoter of 
Th2 responses. 
Under normal circumstances, only minute but perhaps physiologically important 
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quantities of IFN-y are produced. Larger quantities are produced only under 
pathological circumstances such as trauma, infection, cancer, and autoimmunity. 
I F N - Y IS important in the initial phase (aspecific inflammatory and antigen-presenting), 
the middle phase (expansion and differentiation of antigen-reactive lymphocyte 
clones), and the end phase (sustained or final inflammation) of immune reactions. 
Defects in the IFN-y mechanism are associated with severe impairment of 
resistance to infections caused by viruses and certain bacteria, in particular, those 
normally killed by activated macrophages. Although IFN-y is often quoted to be a 
'proinflammatory' cytokine, the production of IFN-y during infections or as a result of 
immune reactions can under some circumstances enhance and in others inhibit 
inflammation and accompanying tissue damage. However, massive production of 
IFN-y, occurring as part of the so-called acute cytokine release syndromes, is often 
associated with severe systemic manifestations, such as generalized bleedings and 
lethal shock. 
1.4-7 Tumor Necrosis Factor a (TNF-a) 
TNF-a, also known as cachectin, and TNF-(3, also known as lymphotoxin, are 
two closely related proteins (about 34% amino acid residue homology) that bind to 
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the same cell surface receptors and produce a vast range of similar, but not identical 
effects (Carswell EA 1975, Beutler B 1985). TNF-a is synthesized as a propeptide 
and then processed intracellularly by an enzyme called TNFa—converting enzyme 
(TACE) to its mature, secreted form, which contains 157 amino acids. TNF-a binds as 
a trimer to its receptor and with each trimer binding to two or three copies of the 
receptor simultaneously. This results in ligand-mediated cross-linking of the receptors 
and transmits signals into the cell (Tristram GP Medical Immunology 2001). 
TNF-a is a mediator that induces anorexia, loss of body weight, dehydration, and 
loss of body proteins and lipid. It regulates the synthesis of several metabolic enzyme 
(e.g. lipoprotein lipase), increases the level of cytokine-induced synthesis of acute 
phase proteins, and accelerates amino acid uptake, energy expenditure, lipolysis and 
protein turnover rate. 
TNF-a is also a proinflammatory cytokine. It is chemotatic to monocytes and 
neutrophils. Stimulation of these cells with TNF-a 
induces phagocytosis, promotes adherence of these cells to endothelial cells, and 
generates free radicals of oxygen-superoxide anion and hydrogen peroxide. The 
cytokine also induces the synthesis of a proinflammatory cytokine, lL-8, and other 
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chemotactic cytokines that regulate the migration, degranulation, and respiratory burst 
response of neutrophils. It also induces the synthesis of other chemokines, such as 
MCP-1, that promotes accumulation of monocytes at the site of inflammation. In 
several inflammatory diseases like rheumatoid arthritis and related autoimmune 
diseases, TNF-a is produced in the inflammatory sites, suggesting its role in tissue 
degradation as well as in augmentation of an inflammatory response (Feldmann M 
1995). 
1.5 General outline of cell surface receptors implicated in sepsis 
1.5-1 C D l l b 
C D l l b , an a subunit of the P2 integrin molecule, is a member of the 
(CD 11/CD 18) family of glycoproteins that are involved in neutrophil adhesion, 
diapedesis, and phagocytosis. It is the receptor for C3bi (Figure 1.1), a component 
of the complement cascade (Pettit EJ 1994, Wittliaut R 1994), and is stored in 
primary and secondary intracellular granules within unstimulated neutrophils and 
leucocytes (Miller LJ1987, Simms HH 1995, Rebuck N 1994). C D l l b is normally 
expressed at a very low level on the surface of neutrophils and increases substantially 
within a few minutes after the cell comes into contact with bacteria or endotoxins 
(Lehr HA 1995, Simms HH1995). This unique property enables C D l l b to be used 
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as a potential ‘early warning' marker for the detection of bacterial infection. Increase 
of neutrophil C D l l b expression during viral and fungal infections has been 
demonstrated in vivo and in vitro studies (McFarland HI 1992, Roberts RL 1994, 
Newman SL 1995). Abughali et al reported that the total cell content of CDl lb/CD18 
on neutrophil lysates from neonate (>37 weeks gestation) was about 60% of that in 
adult neutrophils (Abughali N 1994). Laura et al also showed that a direct relationship 
between the total cell content of CDl lb/CD 18 in neutrophils of premature infants and 
their gestational age (Laura T 1996), implicating the severity of host defense 
impairment in premature infants. 
1.5-2 CD64 
The CD64 (FcyRl) antigen is one of the three FC receptors for immunoglobulins 
(IgG). The others are human FcyRll (CD32 antigen) and human FcyRIIl (CD 16 
antigen), which are situated on the surface of the leucocytes (van de Winkel JGJ 1991, 
1993). While FcgRlI and FcgRlII are low affinity receptors for immunoglobulin, 
FcgRI binds with high affinity. CD64 is predominantly expressed in monocytes, 
whereas CD32 and CD 16 are expressed in granulocytes and NK cells, respectively. 
The CD64 antigen is expressed on monocytes, macrophages, at very low levels 
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on PMN, and on a subpopulation of circulating dendritic cells (Fanger NA 1996). 
Soluble human FcyRl molecules have also been found in human serum (Ernst LK 
1992). Three genes have been characterized for FcyRI. Each gene consists of six 
exons, spans over 9.4 kilobases and localises in chromosome 1. CD64 is an early 
granulomonocytic lineage marker on CD34+ hemopoietic progenitors (Olweus J 
1996). This high affinity FcyRI is involved in the process of phagocytosis and 
intracellular killing of pathogens. It is also expressed at a very low level on the 
surface of unstimulated neutrophils. During bacteria infection, the expression of 
CD64 on activated neutrophils is markedly increased in term and preterm newborn 
infants (Fjaertoft G 1999, Qureshi SS 2001 and Laysec-Espinosa E 2002). 
1.5-3 CD45RO 
The CD45 antigen (leuckocyte common antigen) is a family of membrane 
glycoproteins that are densely expressed by cells of the haematopoietic origin 
(Thomas ML 1988，1989). At least five human isoforms, ranging in molecular mass 
from 180 to 220kD, have been identified (Pulido R 1989, Rothstein DM 1991, Streuli 
M 1988). Each isoform shares a common intracellular domain having protein tyrosine 
phosphatase activity, which is involved in T cell activation (Makenney DW 1995). 
The CD45 isoforms will switch their expression from the long to the short isoform 
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when T lymphocytes are activated with mitogen such as PHA or concanavalin A 
(Akbar AN 1998, Pinto L 1991). In human, this switch results in a change from the 
expression of CD45RA isofomi (MW 190 kD to 220 kD) to the shorter CD45RO 
isoform (180kD) (Akbar AN 1988). Thus, CD45RO and CD45RA have been termed 
as memory antigen and naive antigen for T cells. 
The vast majority (> 90%) of T lymphocytes present in umbilical cord blood 
express CD45RA antigen, but not CD45RO antigen. During childhood, the relative 
frequency of circulating CD45RA+ cells gradually declines and the frequency of 
CD45RO+ cells increases, reaching 40-60% in adults (Tedder TF 1985，DePP 1988). 
1.5-4 CD25 
The interleukin-2 receptor is consisted of two glycoprotein chains, an alpha chain 
(IL-2Ra) and a beta chain (IL-2R(3) (Tsudo M 1986，Sharon M 1986 and Smith KA 
1989) which act together to form a high affinity receptor that transduces the IL-2 
signal. IL-2Ra, also named as CD25 or Tac antigen, is a 55kDa transmembrane 
glycoprotein composed of 351 amino acids, whereas IL-2p is a 75 kDa 
transmembrane glycoprotein composed of 575 amino acids (Schwarting R 1989). 
CD25 is expressed in a subset of peripheral blood lymphocytes (Jackson AL 1990). 
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The IL-2Ra and lL-2Rp have low and intermediate binding affinity to lL-2, 
respectively. The high affinity 1L-2R is composed of both a and p subunits (Sharon M 
1986 and Teshigawara K 1987). Taga K et al further characterized the expression of 
IL-2Ra and IL-2Rp on T cell subset (CD4+ and CD8+ T cells) from adult and 
neonatal blood (Taga K 1991). They found that the reciprocal expression of 
lL-2Ra and IL-2R(3 was observed in CD4+ and CD8+ T cells from adult blood. While 
there are many CD4+ T cells expressing IL-2Ra, the expression of IL-2Rp on CD4+ 
cells are rare. On the other hand, CD8+ T cells expressed significant amount of 
1L-2RP but little lL-2Ra. In marked contrast to adults, both CD4+ and CD8+ T cells 
from newborns, which seemed to consist mainly of naive populations, showed only 
negligible expression of IL-2R subunits. It was found that IL-2R subunits appeared to 
be preferentially expressed on CD4+ and CD8+ T cells with memory phenotypes 
(CD45RA+ T cells) in the adult blood (Taga K 1991). 
1.6 Aims of study 
(1) To evaluate the usefulness of four leukocyte surface antigens, including two 
lymphocyte antigens (CD25 and CD45RO) and two neutrophil antigens 
( C D l l b and CD64) for diagnosing late-onset infection in preterm very low 
birthweight infants. 
_ 
Chapter 1; Introduction and Objectives 
(2) To define the diagnostic utilities, including sensitivity, specificity, positive and 
negative predictive values, and optimal cutoff values of these markers for 
diagnosing late-onset infection. 
(3) To investigate the pattern of proinflammatory (IL-2, IL-6, TNF-a and IFN-y) 
and anti-inflammatory cytokine (IL-4 and IL-10) responses in preterm very low 
birthweight infants with systemic infection, and compared them with 
age-matched infants without sepsis. 
_ 
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Figure 1.1 Diagrammatic representation of the different receptors that may mediate 
nonimmune phagocytosis (MBP = mannose-binding protein; CRP = C-reactive 
protein). 
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Figure 1.2 Function of Thl and Th2 cells in the immune response. The red 
dotted arrows present the inhibition or down regulation process (APC = 
antigen-presenting cells; Tcp = Cytotoxic T precursor cells; PC = plasma cells; 
M 0 = macrophages; B = B cells) 
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2.1 Patient inclusion criteria and classification 
All preterm infants were recruited from the Neonatal Unit at the Prince of Wales 
Hospital, Hong Kong. They met the criteria of having (i) birth weight < 1500 g, (ii) 
postnatal age > 72 hours, (iii) signs and symptoms suggestive of systemic infection 
and requiring full sepsis evaluation and antibiotic treatment, and (iv) parental consent. 
Infants with severe congenital or chromosomal abnormalities were excluded from the 
study, as the conditions might influence the immunological systems of the infants. 
The antibiotic treatment included vancomycin, aminoglycoside or 3 � � g e n e r a t i o n 
cephalosporin. The recruitment of suspected infection episodes was earned out 
prospectively over a period of 22 months. 
The recruited preterm infants were prospectively classified into three categories 
as: (i) Group 1，the 'infected group' which consisted of episodes that had been 
confirmed to have septicemia, meningitis, pneumonia, peritonitis, systemic fungal 
infection or necrotising enterocolitis (NEC; stage II or above in Bell's classification) 
(Walsh MC 1988). A subgroup of severely infected infants who developed 
disseminated intravascular coagulation (DlC) and clinically presented with elevated 
serum D-dimer concentration > 1.0 ^g/mL (normal range 0.5 - 1.0 fig/mL), 
thrombocytopenia with platelet counts < 50 x 1 ( n o r m a l range > 150 x 10"Vl) 
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and deranged coagulation with prolonged activated partial thromboplastin time > 120 
seconds (normal range 26.2 - 40.1 seconds) were also identified, (ii) Group 2 was 
defined as the 'non-infected group' and consisted of episodes that met the initial 
screening criteria for suspected clinical sepsis but were subsequently found not to 
have positive bacterial or fungal cultures in blood, cerebrospinal fluid or urine 
specimens; radiological evidence of pneumonia or necrotising enterocolitis; and the 
infant continued to improve after antibiotic treatment was stopped, (iii) Group 3 was 
the 'control group' and consisted of blood samples taken once from 20 well, VLBW 
infants between week 1 and 12 of postnatal age for cytokines, C-reactive protein 
(CRP) and cell surface antigen measurements. The collection of these blood samples 
coincided with the weekly routine screening of haemoglobin concentration and liver 
function. 
2.2 Sample collection and sepsis screening 
Each pertenn infant might have more than one episode of infection. In each 
episode, a full sepsis screen was performed, which included cerebral spinal fluid 
(CSF), blood, urine, stool, and endotracheal aspirate (infants on respirator) cultures 
for bacteria and fungi; removal and culture of indwelling central lines or catheters; 
and cultures of specific sites and surgical specimens such as peritoneal fluid, abscess, 
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and biopsy specimen. Chest radiograph was routinely performed during the initial 
screening procedure and an abdominal radiograph would be requested when patients 
were presented with signs suggestive of intra-abdominal pathology. Haematological 
and biochemical laboratory investigations including a complete blood count, 
differential white cell and platelet counts; arterial blood gas; and serum glucose 
concentration were also performed. 
In addition to our routine serial CRP screening that was measured by a turbidity 
assay against control standards, as specified by the manufacturer (Behring 
Diagnositics Inc., Westwood, MA, U.S.), plasma specimens for IL-2, lL-4, IL-5, 
IL-10, IFN-y and TNF-a were measured by Cytometric Beads Array (CBA) assay 
[Becton Dickinson, PharMingen, San Diego, California, USA (BDIS)], IL-6 was 
quantified by standard Enzyme Linked Immunoassay (ELISA) (R&D System). The 
expression of lymphocyte cell surface antigens CD25 and CD45RO, and neutrophil 
cell surface antigens C D l l b and CD64, were measured by flow cytometry. The first 
sample was taken at the time of the initial sepsis evaluation (0 hour), and two further 
samples were obtained at 24 and 48 hours after the onset of infection for monitoring 
the clinical progress and response to antibiotic treatment. This schedule of blood 
sampling coincided exactly with our Unit's policy for serial blood count and CRP 
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measurements after a suspected episode of infection had been identified. 
Intravenousbroad spectrum antibiotics were started immediately after the sepsis 
screening and the first set of blood sample had been collected. 
2.3 Quantitation of cell surface antigens 
The flow cytometer (FACS Calibur, BDIS) was routinely optimized using the 
CaliBRITE beads (BDIS). Before each analysis, the QuantiBRlTE PE beads (Figure 
2.1a) (BDIS) conjugated with four predefined levels (Figure 2.1b) of PE molecules 
were used to construct a standard linear regression curve (Figure 2.1c). The slope and 
intercept of this specific standard curve were computed by the QuantiQuest 
software(BDlS). By comparing the mean fluorescence intensity of the cell with the 
standard curve, the antibody bound sites per cell could be calculated. 
Ethylenedaminetetraacetic acid (EDTA) blood samples collected from indwelling 
arterial lines or venepunctures were immersed in ice and immediately transported to 
the laboratory for processing. All antibodies were purchased from BDIS. The CD64 
antibody was of QuantiBRlTE grade (BDIS) which indicated that >95% had the 
antibody to PE ratio of 1:1. QuantiBRlTE reagents for other antibodies were not 
commercially available at the time when this project was first started. Each blood 
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sample was stained with 10 |LIL of each antibody in the following tubes: 
CD 16-Fluorescein-Isothiocyanate (F1TC)/CD 11 b-Phycoerythrin (PE)/CD45-Peridinin 
Chlorophyll Protein (PerCP), CD3-FITC/CD25-PE/CD45-PerCP, 
CD3-FITC/CD45RO-PE/CD45-PerCP, CD64-PE/CD45-PerCP, and the respective 
isotypic controls. The antibody CD3 was used for the flow cytometric selection of 
the T-lymphocyte population and CD45 for three parts differentiation of white blood 
cells. All tubes were incubated at room temperature in the dark for 20 minutes except 
the tube for CD64 analysis. After incubation, 2 mL of Ix FACS Lying Solution 
(BDIS) were added and incubated for a further 10 minutes in the dark for red cell lysis. 
After washing with 3 mL of Ix FACS Shield Fluid (BDIS) and centrifugated at 200 g 
for 5 minutes, the cells were fixed with 500 fjJL of 1% paraformaldehyde before 
cytometric analysis. As the antibody-PE ratio (Gratama JW 1995) and the expression 
of neutrophil C D l l b might be temperature sensitive (Weirich E 1998), this affecting 
the outcome of the quantitative analysis, we further performed the analysis using 
QiiantiBRITE grade C D l l b antibody (specially requested from BDIS) for verification 
of these conditions. The whole procedure was carried out according to the previous 
condition except that the staining temperature was kept at 4°C. 
The CD64 antibody staining was performed according to the manufacturer's 
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recommendation, using the lyse-no-wash method. These samples were incubated at 
room temperature for 1 hour, and the red blood cells were lysed by 1 mL Ix FACS 
Lysing Solution (BDIS) for a further hour in the dark at room temperature. 
2.3-1 Cell acquisition and calculation 
The FACS Calibur cytometer was used for the acquisition and analysis of cell 
surface antigens. Thirty thousand events were acquired by the CellQuest software 
(BDIS). The three parts differential populations including lymphocytes, monocytes, 
and granulocytes were identified and gated by their CD45-PerCP/side-scatter profile 
(Figure 2.2a). For the cell acquisition of neutrophils for CDl lb analysis, the antibody 
CD 16 was employed to characterize the granulocytes into CD 16 positive neutrophils 
and CD 16 negative eosinophils (figure 2.2b). The expression of cell surface antigens 
(Figure 2.2c) was represented by their geometric mean values. The number of 
antibodies bound per cell was derived from the log-log linear equation [(log 
(geometric mean) = slope * log (PE molecules/beads) + intercept)] generated from the 
standard PE-beads with the software of QuantiQuest (BDIS). Similarly, the 
expressions of CD45RO and CD25 on the lymphocyte population were based on the 
gating of lymphocytes by the CD45-PerCP/side-scatter profile (Figure 2.3 and Figure 
2.4 respectively). 
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For the analysis of neutrophil CD64 expression, both the monocyte and 
lymphocyte populations were included in a (R2) region and the neutrophil population 
gated in another region (Rl) (Figure 2.5). The CD64 expression was strongly positive 
on monocytes but negative on lymphocytes. Therefore, monocytes and lymphocytes 
acted as a positive and negative control, respectively. The histogram of CD64 was 
then derived from the gated neutrophil region and the geometric mean was generated 
as previously described. 
2.4 Quantitation of plasma cytokines 
Cytokine levels of IL-2, IL-4, IL-5, IL-6, IL-10, interferon-y (IFN-y) and tumor 
necrosis factor-alpha (TNF-a) in the plasma of VLBW infants were analysed. The 
blood samples collected from indwelling arterial lines or venepunctures were kept in 
ice and immediately transported to the laboratory. The plasma samples were separated 
by centrifugation (1900 g for five minutes) at 4°C. They were aliquoted to 200 |_iL and 
stored at -80"C until analysis. 
Plasma interleukin-6 (IL-6) was measured by a sandwiched enzyme linked 
immunoassay (R&D System Inc. Minneoapolis, U.S.A.). The assay standards (100 |iL) 
and patient's plasma (100 |j.L) were added into a 96 well microplate that was 
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pre-coated with IL-6 monoclonal antibodies. After two hour of incubation to allow 
antigen and antibody binding at room temperature, the plate was washed three times 
to remove the unbound substance before adding 200 |JL enzyme-linked polyclonal 
(conjugated) antibody specific for IL-6. After a further two hour incubation, the plate 
was washed three times to remove the unbound conjugated antibodies, The substrate 
solution (200 ^iL) was added to the wells and the colour was developed in proportion 
to the amount of IL-6 bound in the initial step. The colour development was stopped 
by 2N sulfuric acid. The optical density of each well was measured with a microplate 
reader (Dynatech MR5000, MIKROTEK Laborsysteme, Overath, Germany) at 450 
nm with the reference optical density at 570 nm. The concentration of lL-6 in the 
patient's plasma was derived from the assay standards. 
The other cytokines except IL-6 were analysed by the Cytometric Beads Array 
(CBA) assay (BD Pharmingen). CBA is based on using a series of particles (beads) 
with discrete (FL-3) fluorescence intensities to simultaneously detect multiple soluble 
analytes. Each bead provides a capture surface for a specific protein and is analogous 
to an individually coated well in an ELISA plate. The capture bead mixture is in 
suspension to allow for the detection of multiple analytes in a small volume sample. 
In this test, six cytokines, including IL-2, IL-4, IL-5, ILIO, IFN-y and TNF-a were 
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pre-coated onto six beads with distinct fluorescence (FL-3) intensities (Figure 2.6). 
When the captured bead mixtures were mixed with test samples or recombinant 
standards and PE-conjugated secondary antibodies (FL-2), a sandwich complex was 
formed. The flow cytometer acquired the data from resolving the captured beads with 
distinct (FL-3) fluorescence intensity and secondary antibodies with the PE- (FL-2) 
fluorescence. By applying the 4-parameter curve fit option of the BD software (BDIS), 
it is possible to extrapolate values for sample intensities not falling within the limits of 
the standard curve. The sensitivity of CBA for each cytokine is shown in Table 2a. 
2.4-1 Cytometric Beads Array assay 
The CBA kit was firstly brought to room temperature for at least 15 minutes 
before the experiment was performed. Two hundred microlitre assay diluent was 
added to the cytokine standards. This allowed the reconstituted cytokine standards to 
equilibrate for at least 15 minutes before doubling dilutions were carried out. The 
standard concentrations were between 0 pg/mL and 5000 pg/mL with 10 intervals 
(Figure 2.6). Preparation of the captured bead was based on the number of test sample 
required. Ten microlitre of each bead solution was added to each assay tube. The 
reaction was performed with 50 mL of bead mixture with equal amount of test 
samples or cytokine standards, and the PE-conjugated antibodies. All assay tubes 
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were then incubated at room temperature for three hours in the dark. After washing 
with 1 mL of washing buffer, assay tubes were centrifliged at 200 g, 4°C for 5 minutes. 
The supernatant was discarded and the pellet resuspended in 300 ]xL of washing 
buffer dilution. Before data acquisition, the flow cytomter must be calibrated with the 
cytometric setup bead that was provided with the kit. The setup bead was used to 
optimize the detector and the compensation setting. The bead singlet was gated and 
total 3000 beads events were acquired. 
The concentration of each cytokine in the plasma sample was calculated from the 
standard curve of individual cytokine standards (Figure 2.7). The unit of the six 
I 
cytokines was expressed in pg/mL. 
2.5 Statistical Analysis 
The comparison of plasma cytokines between infected (group 1 at 0 hour), 
non-infected (group 2 at 0 hour), and healthy control (group 3) were analysed by the 
Kj-uskal-Wallis test and P test. The Mann-Whitney U test was also used to compare 
the corresponding plasma cytokine concentrations between the infected and 
non-infected infants at 24 and 48 hours, and the subgroup analysis of infected patients. 
The Spearman's correlation was employed to compare the relation between different 
_ 
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cytokines. 
The receiver operation characteristic curve (ROC) graph was used to determine 
the cutoff value of the infection markers. The ROC graph with the maximum area 
under the curve was chosen, and the optimal cutoff value for individual markers was 
then determined on the graph by minimizing the number of misclassified episodes. 
The ideal diagnostic markers should identify all genuinely infected episodes {i.e. 
100% sensitivity) and at the same time would not misclassified too many non-infected 
cases (i.e. a high specificity). The optimal cutoff value was, therefore, chosen with the 
sensitivity approaching 100% and specificity > 85%. All statistical tests were 
performed by SPSS for Windows (Release 10, SPSS Inc., Chicago, Illinois, USA) and 
MIXREG computer software (Comput Methods Program Biomed), which used the 
maximum marginal likelihood, expectation and maximization algorithm, and Fisher 
scoring solution. A p value of < 0.05 was considered to be statistically significant. All 
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Figure 2.3. Flow cytometric analysis ofCD45RO on CD3+lyniphocytes. (a) 
S-ptrts differentiation by CD45-PetCP vs sidc-«caUcr profile, (b) The 
selcctkm of CD45RCH cells (R4) on upper right hand panel of the quadmils. 
(c) The histogram of CD3+/CD45RtH- cells. 
— 
Chapter 2; Materials and Methods 
蕃: n CD3+/CD25+ 
i： •.墨‘ 、， 
协 co4tcf 祐 1。 丨。• 一 1 
— 
Histogram of CD3+/CD25+ cells 
a -
i -
2 . (C) 
“ i , | J | t i | 
丨 oO tot ‘ ,�< 
Figure 2,4 Row cytomdric amtysis of CD25 on CD3. lymphocytes, (a) 3-parts 
differentiation by CD45-PCTCP va side-scatter profite. (b> The selection of CIB+ and 
CD25+ cciU (R4) at the upper right hand panel of the quadrants, (c) The histogram of 
— 
Chapter 2; Materials and Methods 
i ] 舊 ’ I 5] “ 
•塞」 ‘ f l f Lymphocytes 
I ： ' ^ - m k i c I : Ml Monocyte!^ 
i I揭丄子J-
8 . 
Hstogram of neutrophil C064+ve cells 'rT] 
(C) 
O- I , •• , • I M ， * — ‘ 藝 ‘ ‘ ' ' ' ' " ' I -
� t f 10* i r 10' to. 
Figure 2,5 Flow cytometric analysis of CD64 expression on 
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monocytes (R2) by the CD45-PerC:P vs sidc-scatlcr proftle. (b) 
Histogram of monocytes (positive control) and lymphocytes 
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Table 2a 
Sensitivity of Cytometric Bead Array 
Cytokines Median Standard Assay Sensitivity 
Fluorescence Deviation (pg/mL) 
"iL^ 33 ^ ^ 
IL-4 2.3 0.2 2.6 
IL-5 2.6 0.2 2.4 
ILIO 2 .4 0.2 2 .8 
TNF-a 2.0 0.2 2.8 
IFN-y 2.1 0.3 7.1 
The sensitivity for each cytokine using the Human Thl/Th2 Cytokine CBA is defined 
as the corresponding concentration at two standard deviations above the median 
fluorescence of 20 replicates of the negative control (0 pg/mL). 
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Chapter 3 
Cell surface and plasma cytokine markers for the 
diagnosis of late-onset sepsis in preterm, very low 
birth weight (VLBW) infants 
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3.1 Results 
3.1-1 Lymphocyte markers: CD25 and CD45RO 
Good diagnostic markers for neonatal sepsis should be able to differentiate the 
infected from the non-infected cases. Two lymphocytes markers were evaluated in 
this project. During the interim analysis, eighteen episodes were identified to be 
genuine infection in sixty-eight suspected infection episodes. After statistical 
calculation, the expression of CD25 on CD3+ T-lymphocytes in terms of PE binding 
sites per cell was not significantly different in infected infants compared with 
non-infected infants at 0 hour, 24 hours and 48 hours (Figure 3.1). The median and 
interquartile range of CD25 on CD3+ T-lymphocyte were summarized in Table 3a. 
The optimal cut-off value of CD25 was 3100 PE-molecules bound per cell. The range 
of sensitivity, specificity, positive predictive value and negative predictive value of 
CD25 were 50 to 75%, 34 to 43%, 21 to 27 % and 65 to 81% respectively, during the 
three specific time points {i.e. 0, 24, and 48 hours) of sepsis evaluation. As CD25 
marker did not satisfy the pre-detemiined criteria of having the sensitivity and 
specificity > 75% during a single measurement, it was considered unreliable for 
predicting infection in VLBW infants. Hence, the CD25 on CD3+ T-lymphocyte 
surface marker was excluded from further investigation. 
The other lymphocyte marker was CD45RO. Statistical test showed that 
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CD45RO expression on T-lymphocytes in the infected group was significantly higher 
than that of the non-infected group at 0, 24, 48 hours (p < 0.006, 0.07, 0.02 
respectively) (Figure 3.2). The median and interquartile range were summarized in 
Table 3a. The optimal cut-off value was 2900 PE-molecules bound per cell. The 
sensitivity, specificity, positive predictive value and negative predictive value were 65 
to 83%, 50 to 100%, 43 to 100% and 82 to 87%, respectively, during the three specific 
time points (i.e. 0，24’ and 48 hours) of sepsis evaluation. As both of the sensitivity 
and specificity did not fulfill the predetermined criteria of having values greater than 
75%, this marker was also excluded from further evaluation. 
3.1-2 Neutrophil markers 
After two years of recruitment, there were 37 infected, 90 non-infected and 
twenty control episodes. The clinical characteristics of the three study groups were 
summarized in Table 3b. There were no statistically significant differences in the 
median gestational age of infected, non-infected and control groups which were 29.2, 
28.6 and 29.1 weeks, respectively. The birth weight, Apgar scores at 1 and 5 min, 
male and female ratio among the groups were also not significantly different. 
In this study, infants might have been investigated for suspected infection more 
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than once. A total 127 episodes of suspected clinical sepsis were studied in 80 very 
low birth weight infants. One, one, seven, and 27 patients had sepsis screen performed 
five, four, three, and two times, respectively. The remaining 45 infants received only 
one sepsis screen. Microbiological results were taken as the gold standard for the 
diagnosis of infection. Thirty-seven of the 127 episodes of suspected clinical sepsis 
were confirmed infection or necrotizing enterocolitis. The details of pathologies and 
organisms of the infected episodes were summarized in Table 3c. 
3.1-2a CD64 
Neutrophil surface antigen CD64 expression was significantly elevated in the 
infected group compared with the non-infected group. Figure 3.3 showed the flow 
cytometric analysis of CD64 expression on neutrohphils in a typical infected infant 
and in a non-infected infant. The optimal cut-off value of CD64 expression was 4000 
PE-molecules bound/cell. This value was derived by minimizing the number of 
misclassified episodes over all possible cutoff values for the first 48 hours. The 
postnatal age of blood sampling did not differ significantly among the three groups 
(Table 3d). Surface neutrophil marker CD64 in the infected group was significantly 
increased compared with the corresponding values of the non-infected group at 0 and 
24 hours (p < 0.05) (Figure 3.4). Likewise, the levels of markers in the infected group 
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at 0 hour were also significantly higher than those of the control group (p < 0.001, 
Table 3d). In contrast, no significant difference was detected between the levels of the 
non-infected group at 0 hour and the control group (Table 3d). The specificity, 
sensitivity, positive and negative predictive values of CD64 expression were 97%, 
90%, 80% and 99%, respectively at 24 hours. These results were the best among all 
cell surface antigens in the study. The detail results of the following two days were 
shown on Table 3e. 
3.1-2b C D l l b 
The other investigated neutrophil marker CDl lb was selected from CD 16 
positive granulocytes (Figure 2.2b). The use of CD 16 staining was to differentiate 
between the eosinophils and neutrophils. The optimal cut-off value of C D l l b 
expression was 10450 PE-molecules bound/cell. Unlike the neutrophil CD64 surface 
marker, the C D l l b result showed that it had low sensitivity (20-70%), specificity 
(71 -75%), positive and negative predictive values (detail results shown on Table 3e) 
despite the fact that it was statistically different in infected infants as compared with 
non-infected or the control group at 0 hour (p < 0.0001) (Figure 3.5). However, a 
significant difference in expression was found at 24 hours and 48 hours. There was 
also no significant difference in expression between the non-infected and the healthy 
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control group at 0，24 and 48 hours. 
3.1-3 Purified C D l l b 
To address the issue of the purity of antibody-PE ratio (1:1) and the sensitivity 
of CD 1 lb to incubation temperature (4�C)’ we concurrently analyzed 67 infective 
episodes using the customized CDllb-PE conjugate of QuantiBRlTE grade at a 
staining temperature of 4°C. The sensitivities and specificities of the purified C D l l b 
QuantiBRlTE reagent ranged between 16% - 70% and 47% - 52% respectively, 
demonstrating that the modified procedures with purified reagent and lower 
temperature did not improve the diagnostic utilities of the C D l l b test. 
3.1-4 Comparison of cell surface markers 
Comparing the two lymphocyte markers, CD45RO had moderate low sensitivity 
(65% to 83%) and variable specificity (43% to 100%) but its diagnostic utilities were 
better than CD25 which demonstrated very low sensitivity (50% to 75%) and 
specificity (34% to 43%). Between the two neutrophil surface antigens, CD64 and 
C D l l b , CD64 exhibited high sensitivities (87% - 97%) and specificities (88% - 90%) 
whereas C D l l b showed comparatively low sensitivity (24% to 70%) and specificity 
(72% to 75%) (Table 3e). The receiver operation characteristic curve (ROC) showed 
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that CD64 was the best marker among the four cell surface antigens at the time of 
onset and the following 48 hours (Figure 3.8-3.10). 
3.1-5 Interluekin 6 (IL-6) and C-Reactive Protein (CRP) 
IL-6 was the only cytokine chosen in this study for the assessment of its 
usefulness as a diagnostic marker for sepsis in preterm, VLBW infant. The result 
showed that the IL-6 level in plasma was significantly increased in the infected group 
compared with the corresponding values of the non-infected group at 0 and 24 hours 
(p < 0.05). The peak concentration of IL-6 was found at 0 hour (Figure 3.6). 
Comparatively, the level of IL-6 in the infected group at 0 hour was also significantly 
higher than that of the control group (p < 0.0001) (Table 3d). In contrast, there was no 
significant difference in the level of IL-6 between the non-infected group and control 
group at time 0 hour. 
CRP is the routine clinical test for the diagnosis of infection in our medical unit. 
The level of CRP in infected infants peaked at 24 hours after the onset of sepsis 
evaluation (Figure 3.7). There was significant difference when infected group was 
compared with non-infected group at both 0 hour and 24 hours (p < 0.05). Similar to 
other diagnostic markers in this study (lL-6, CD64 and CD lib) , the CRP level in the 
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infected group was significantly higher than that of the control group (p < 0.0001) 
(Table 3d). There was no statistical difference between the CRP levels of non-infected 
group and control group at 0 hour. 
3.2 Combined analysis of diagnostic markers 
We further analyse the cell surface antigens, plasma cytokine and CRP in 
combination, and found that the combination of CRP at 0 hour with neutrophil surface 
marker CD64 at 24 hours could further enhance both the sensitivity and the negative 
predictive value of the test to 100%, i.e. all positive cases could be identified and no 
false negative case was diagnosed. Similarly, combining plasma lL-6 at 0 hour with 
neutrophil surface marker CD64 also increased the sensitivity and negative predictive 
value to 100%. For the time points at 24 hours and 48 hours, the sensitivity and 
negative predictive values of the combined analysis among these three diagnostic 
markers were 95-97% and 97-99%, respectively (Table 3f). 
3.3 Discussion 
The surface antigens CD25 and CD45RO of T lymphocytes were evaluated as 
markers for diagnosis of late-onset sepsis in preterm, VLBW infants. CD45RO+ T 
cells are known as memory cells because they are derived form CD45RA+ T cells 
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after antigenic or mitogenic stimulation and provide the recall response to an antigen 
(Vitetta ES, 1991). Healthy infants who have not experienced infection express 
CD45RO on a minor population of T cells (Yamada A 1992, Beck R 1994, Michie C 
1995). However, in infants who have come into contact with infectious 
micro-organisms, the number of CD45RO+ T cells increases substantially (Duse M 
1994). In this study, quantitative analysis of CD45RO+ T cells had relatively low 
sensitivity (65-83%) but it gave high specificity (50-100%) for the identification of 
infected and non-infected preterm infants. Bruning et al (Bruning T 1997) found that 
the specificity of CD45RO+ T cells was 94.6% and the sensitivity was 48.6% for 
diagnosing neonatal infection. The discrepancy of the result between this study and 
that of Bruning might have been related to the different populations studied. Our 
patients were preterm infants, whereas their patients were term neonates up to 3 
month of age. The delayed conversion of CD45RO+ T cells from CD45RA may be 
explained by the time required to activate CD45RO+ T cells after they came into 
contact with antigenic substances. Further, Hodge et al (Hodge S 1998) showed that 
the CD45RO was a 'late' T cell activation marker, and the detectable level might not 
be found in the peripheral blood until several days after infection. 
Although some reports (Spear ML 1995, Godula U (2001) suggested that the 
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relative proportion of CD25+ T cells was significantly increased in infected full-term 
neonate, the analysis of CD25+ in T cells gave disappointing results in our study (Ng 
PC 2002). However, the former studies did not quantify the expansion of surface 
antigen on T cells nor calculated the diagnostic utilities. A recent study (Hodge G 
2004) also showed that CD25+ T cells were up-regulated during sepsis but theses 
investigators identified only 10 out of the 17 infected term infants, implying rather 
poor sensitivity and specificity values. 
Although both lymphocytes markers were excluded from the study during the 
interim analysis, the expression of CD45RO on lymphocyte CD3+ T cells gave 
slightly better results as well as sensitivity, specificity, positive and negative 
predictive values compared with the expression of CD25 on lymphocyte CD3+ T cells. 
A recent study (Hodge G 2004) suggested that a population of CD45RA+ and 
CD45RO+ T-lymphocytes were up-regulated in early neonatal infection. They 
recommended a combination of CD69 on NK cells with dual positive 
CD45RA/CD45RO and CD25 on T-cells to be the most sensitive and specific markers 
for the detection of neonatal infection. However, this study involved very few patients 
and analyzed only the percentage of T-lymphocytes expressing these markers and not 
the quantitative analysis of the antibody-PE bound per cell as performed in our study. 
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Hence the effects of the latter markers on neonatal infection required further 
evaluation. 
C D l l b is an a subunit of the P integrin adhesion molecule. The expression 
level of C D l l b on neutrophils is low under normal condition without infection. 
However, its expression would increase substantially within a few minutes after these 
cells come into contact with bacteria or endotoxin (Lehr HA 1995，de Haas M 1995). 
This unique property enables C D l l b to be used as a potential early warning marker 
for detection of bacterial infection. Although C D l l b has been previously suggested to 
be a highly effective marker for diagnosing early-onset infection (infection occurs 
within 24 hours of age) in term infants (Weirich E 1998), our data did not support this 
notion. Despite the fact that C D l l b in infected VLBW preterm infants showed a 
significantly higher response at day 0 compared with non-infected cases (Figure 3.5), 
its relatively low sensitivities (24% - 70%) and specificities (71% - 75%) made it an 
unreliable infection marker for identifying late-onset nosocomial bacterial infection in 
preterm infants. In addition, a recent study investigating over 10 leukocyte surface 
markers was also unable to confirm the diagnostic value of C D l l b for predicting 
infection in preterm neonates (Weinschenk NP 2000). Several plausible explanations 
might have accounted for the discrepancy observed between different studies (Weirich 
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E 1988, Weinschenk NP 2000, Ng PC 2002). Firstly, the populations being evaluated 
were very different. Both Weinschenk et al (2000) and our study investigated only 
preterm (24 - 30 weeks' gestation) and VLBW infants, respectively, whereas the 
earlier study by Weirich et al. involved mainly term infants. The expression of C D l l b 
in neutrophils has been shown to be under developmental control, being 
down-regulated in preterm compared with term infants and adults (McEvoy LT 1996, 
Abughali N 1994; Kaufman D 1999). The mobilization of C D l l b by chemotactic and 
bacterial stimulation was also reported to be impaired in neonates (Torok C 1993). 
Thus, it is possible that the mechanism of C D l l b activation in response to septic 
challenge may not be fiinctionally mature or operational in some of our VLBW 
infants. Secondly, there were technical differences in the methods of measurement 
between different trials and that PE-molecules bound per neutrophil was 
quantitatively assessed only in the our study. Although two different staining methods 
have been used, there was no improvement of C D l l b as a marker for the diagnosis of 
late-onset sepsis in VLBW infants. Thirdly, unlike early-onset infection in which the 
pathogens are usually acquired within a short and well defined period during 
peripartum, one can never be certain in late-onset nosocomial sepsis at which phase of 
the infection blood was collected for determination of CDl lb . Since activation of 
C D l l b expression on neutrophils occurs early in the disease process, a delay in 
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recognition of sepsis and consequently in obtaining the blood sample, might result in 
missing the peak of CDl lb expression. 
Significant increased in neutrophil expression of CD64 was found in infected 
group compared with non-infected group at all three days. The level of CD64 
expression peaked at 24 hours after the onset (Figure 3.4). CD64 positively identified 
all cases of septicaemia, NEC and central nervous system infection in this series. Only 
one case of coagulase negative staphylococcus pneumonia was misclassified. 
Combining the use of C-reactive protein (CRP) and IL-6 at 0 hour would further 
enhance the diagnostic capability for identifying serious localised chest infection, and 
improve the sensitivity and negative predictive value of CD64 to 100%. Under such 
circumstances, approximately 10% - 14% of non-infected infants would erroneously 
be considered as septic and continue to receive antibiotic treatment unnecessarily. 
Steroids were administrated in both infected group and non-infected group, therefore, 
the level of CD64 would not be affected by steroid treatment. Also in accordance to 
previous findings (Fjaertoft G 1999), patients with Gram-positive septicaemia did not 
differ significantly from Gram-negative or fungal septicaemia in their CD64 
expression. The four cases of infection in which no micro-organisms could be isolated 
from the blood or CSF cultures all presented with unstable temperature, hypotension, 
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recurrent apnoea and severe desaturation. Two of the infants required intubation and 
were re-commenced on assisted ventilation. These infants were judged to be 
genuinely septic based on their strong and persistent signs of infection, and all cases 
were positively identified clinically before the results of the infection markers became 
available. Subsequently, these infants were found to have at least two abnormally 
raised markers of infection (CD64 and CRP 士 IL-6 or CDl lb). All received a full 
course of antibiotic treatment and their progress of clinical improvement bore close 
temporal relation with the normalization of infection markers. Thus, we believed that 
these cases have not been misclassified. However, inclusion of these four cases in the 
non-infected category does not affect the sensitivity and only marginally reduces their 
specificity. Our results are also comparable with those of Layseca-Espinosa et al 
(2002) who showed that the CD64 expression on neutrophils has a very high 
specificity (96.8%). 
The use of cell-surface antigens as markers for infection in preterm infants are 
infrequently reported. To our knowledge, our study represents the first quantitative 
flow cytometric analysis of leukocyte cell-surface antigens for the diagnosis of the 
late-onset nosocomial infection in preterm VLBW infants. Neutrophil surface antigen 
CD64 is a very sensitive diagnostic marker and it should allow clinicians to 
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confidently discontinue antibiotics at 24 hour, without waiting for the definitive 
microbiologic results, in non-infected infants. 
Quantitative flow cytometric analysis applied in this study could further be 
developed into a routine clinical test, with high comparability and reproducibility, 
across different laboratories. Measurement of neutrophil CD64 expression by this 
method is highly specific, relatively inexpensive and can be efficiently performed on 
an ad hoc basis using only minimal volume of blood sample (50 |j.L). Moreover, the 
result of the test can be made accessible within a few hours (< 4 hours) after the 
specimen reaches the laboratory. In order to further validate the value and 
applicability of CD64 for diagnosing life-threatening infection in at risk preterm and 
term infants, prospective studies examining different categories of infections (viral, 
bacterial and fungal), larger number of infants and including those with early-onset 
infection should be performed. 
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Figure 3.1. The level of cell expression of CD25 during the first 48 hours of 
suspected clinical sepsis. Comparison of the range of CD25 between the infected 
and non-infected group is not statistically significant. Data are expressed as 
median, and 25^'' and percentiles. Thick and thin dashed lines and their upper 
and lower boundaries cover the 50出，75th,肌d percentiles, respectively, of 
the non-infected episodes. Bold line (red) and upper and lower boundaries of the 
shaded area represent the 50^'', 75*，and 25^ respectively, of the infected 
episodes. 
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Figure 3.2. The level of cell expression of CD45RO during the first 48 
hours of suspected clinical sepsis. Comparison of the range of CD45RO 
between the infected and non-infected group is statistically significant (p < 
0.007，0.006, 0.02 respectively). Data are expressed as median and and 
75th percentiles. Thick and thin dashed lines and their upper and lower 
boundaries cover the 50th，75th，and percentiles, respectively, of the 
non-infected episodes. Bold line (red) and upper and lower boundaries of 
the shaded area represent the 5 0山， a n d respectively, of the 
infected episodes. 
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Figure 3.3. Flow cytometric analysis of CD64 expression on neutrophils. 
Peripheral blood cells were stained with CD64-PE/CD45-perCP. The 
graph represented a significant increase in CD64 expression in a typical 
infected neonate (solid histogram) when compared with a non-infected 
neonate (open histogram). The mean fluorescence intensity (MFI) values 
were transformed into antibody PE-molecule bound/cell using the 
QuantiQuest computer software. 
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Figure 3.4. The level of cell expression of CD64 during the first 48 hours 
of suspected clinical sepsis. Comparison of the range of CD64 between 
the infected and non-infected group is statistically significant at 0,24 and 
48 hours (p < 0.0001). Data are expressed as median and and 
percentiles. Thick and thin dashed lines and their upper and lower 
boundaries cover the and 25^'' percentiles, respectively, of the 
non-infected episodes. Bold line (red) and upper and lower boundaries of 
the shaded area represent the and respectively, of the 
infected episodes. 
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Figure 3.5. The level of cell expression of C D l l b during the first 48 
hours of suspected clinical sepsis. Comparison of the range of C D l l b 
between the infected and non-infected group is statistically significant at 
day 0 only (p < 0.0001). Data are expressed as median and 25*'' and TS^ *" 
percentiles. Thick and thin dashed lines and their upper and lower 
boundaries cover the 75th， n^d percentiles, respectively, of the 
non-infected episodes. Bold line (red) and upper and lower boundaries of 
the shaded area represent the and 25^'' respectively, of the 
infected episodes. 
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Figure 3.6. Plasma level of IL-6 during the first 48 hours of suspected 
clinical sepsis. Comparison of the range of IL-6 between the infected and 
non-infected group is statistically significant at day 0 only (p < 0.0001). 
Data are expressed as median and and percentiles. Thick and thin 
dashed lines and their upper and lower boundaries cover the 5(^卜，and 
25th percentiles, respectively, of the non-infected episodes. Bold line (red) 
and upper and lower boundaries of the shaded area represent the 50化， 
and 25th respectively, of the infected episodes. 
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Figure 3.7. Plasma level of CRP during the first 48 hours of suspected clinical 
sepsis. Comparison of the range of CRP between the infected and non-infected 
group is statistically significant at 0,24 and 48 hours (p < 0.0001). Data are 
expressed as median and and percentiles. Thick and thin dashed lines 
and their upper and lower boundaries cover the 50出，and percentiles, 
respectively, of the non-infected episodes. Bold line (red) and upper and lower 
boundaries of the shaded area represent the 50出，75th，^^^ respectively, of 
the infected episodes. 
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Figure 3.8. Receiver operating characteristics of four diagnostic markers at the 
onset of infection. 
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Figure 3.9.Receiver operating characteristics of four diagnostic markers 
at 24 hours after onset of sepsis evaluation. 
_ 
Chapter 3: Cell surface and cytokine markers 
48 hours 
t" - i ^ j A 
.81 y • 
* f^wm 1-1F^ r^ i • _ _ _ _ u i i J t i ' U M W M H u 
NUUULI 
p ^ p ^ n n n n A UU UULIIJ UUCI • M VR'M M H 1 i • r^y ^ 
^ ,4. I — J ^ • CD64 
« CD11b 
•21 T^  t4j 口 
. < CD25 
0.0 J ….！ ~^~• 1 • 1 • 1 r - 1 fe 
0.0 .2 .4 .6 .8 1.0 
1 - Specificity 
Figure 3.10. Receiver operating characteristics of four diagnostic markers 
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Chapter 4 
Proinflammatory and anti-inflammatory cytokine 
responses in preterm very low birth weight infants 
(VLBW) with systemic infections 
— 
Chapter 4 ： Proinflammatory and anti-inflammatory cytokines 
4.1 Results 
Plasma cytokines in preterm VLBW infants including proinflammatory 
cytokines (IL-2, IL-6, IFN-y and TNF-a) and anti-inflammatory cytokines (IL-4 and 
IL-10) were investigated in this study. IL-5, a cytokine that principally related to 
allergy and hypersensitivity was also included. All cytokines except IL-6 were 
quantified by cytometric bead array kit (CBA) and the level of IL-6 was measured by 
enzyme-linked immunoassay method. 
Thirty-seven suspected infection episodes were confirmed sepsis or NEC 
diagnosed by microbiological cultures and radiological changes on abdominal 
radiographs. The clinical details were described in chapter 3 (Table 3c). 
Pro-inflammatory cytokines IL-2, IL-6, IFN-y, and TNF-a were found to be 
significantly higher in the infected group, compared with those in the non-infected 
group at the time of sepsis evaluation (0 hour), (p < 0.002) and the healthy control 
group (p < 0.05). The plasma level of IL-6 in infected infants (range from 34-1251 
pg/mL) was much higher than those of non-infected infants (range from 4-11 pg/mL) 
at the onset of sepsis. However, this difference was minimised when antimicrobial 
treatment was administrated to the patients during the following 48 hours. Similar 
result was observed in IFN-y (Table 4a). Except TNF-a at 48 hours, the three other 
proinflammatory cytokines were significantly elevated both at 24 hours and 48 hours 
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in infected compared with non-infected infants (p < 0.04), (Table 4a). No significant 
difference was found between the non-infected group and the healthy control group at 
0 hour. There was also no significant difference in the plasma concentration of IL-5 at 
any time points between the three groups. For anti-inflammatory cytokines, the level 
of IL-10 and IL-4 in infected group were significantly higher than those of 
non-infected group (p < 0.002) and control group (p < 0.05) at 0 hour. The range of 
IL-10 levels at presentation was 20-245 pg/mL, which was much higher than those at 
24 hours (range from 18-83 pg/mL) and 48 hours (range from 0-49 pg/mL), possibly 
indicative of a response to treatment (Table 4a). 
4.1-1 Correlation of cytokine levels in infected patients 
In the infected group, correlation between different cytokines (both 
proinflammatory and anti-inflammatory) was analyzed to investigate the relationship 
of cytokines in the immune system in preterm, VLBW infants. The level of cytokine 
IL-6 was positively correlated with TNF-a (r > 0.36, p < 0.03). It was also 
significantly correlated with IL-10 (r > 0.49, p < 0.002) throughout the study period. 
On the other hand, the level of IL-10 was also significantly correlated with IFN-y (r 
>0.43, p < 0.015) at 0 and 24 hours. 
_ 
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4.2 Subgroup analysis 
The infected group was further categorized into three clinical subgroups for 
analysis. The first subgroup was the infants who developed NEC and those infected 
infants without NEC. The second subgroup was infants who had DIC and infected 
patients but without DIC. The last subgroup was the infants with Gram-positive 
organism infection and those with Gram-negative organism or systemic fungal 
infection (Table 4b). There was no significant difference in the peak plasma cytokine 
concentrations between infants who had NEC and infected infants without the disease. 
In contrast, the peak plasma IL-6 concentrations were significantly higher in patients 
with Gram negative or fungal infections, compared with those with Gram-positive 
sepsis (p = 0.035). In the DIC group, the peak plasma concentrations of IL-6, IL-10 
and TNF-a were significantly higher in the septic infants with DIC, compared with 
those without DIC (p < 0.0001). 
4.2-1 Proinflammatory and anti-inflammatory cytokine ratios 
The data were further analyzed by comparing the ratio between proinflammatory 
and anti-inflammatory cytokines. It was found that the ratio of anti-inflammatory 
cytokines-IL-10 to proinflammatory cytokines-TNF-a was significantly higher in 
patients with DIC than those without DIC, both at time 0 hour and 24 hours (p < 0.01), 
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(Figure 4.1). The death case (section 4.2-2) was excluded in the analysis. Figure 4.1 
showed that the ratio of IL-10 to TNF-a was highest at time 0 hour. It fell 
significantly at the subsequent time points at 24 hours and 48 hours (p < 0.001), 
compared with the corresponding level at 0 hour. 
Another ratio used to evaluate the activity between proinflammatory and 
anti-inflammatory cytokine was the IL- 6 to IL-10 ratio. The ratios at 0 hour, 24 hours 
and 48 hours were significantly higher in infected infants with DIC than in those 
without DIC (p < 0.05). In contrast to the ratio of IL-10 to TNF-a, the peak ratio of 
IL-6 /IL-10 (Figure 4.2) occurred at 0 hour but it did not fall significantly during the 
next 48 hours after the onset of sepsis, 
4.2-2 The deceased case 
One of the sepsis patients suffered from ftmgal septicaemia and DIC died during 
the study. The plasma levels of IL-6 and IL-10 at presentation were 1875pg/mL and 
122.7 pg/mL, which were almost sixty and ten times of the control levels, respectively. 
These levels remained high throughout the time course in the study (Table 4c). The 
ratio of IL6 to IL-10 of this patient continued to increase even after commencement of 
antibiotic treatment. This trend was different from the other DIC survivors in which 
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the ratio was shown to be decreased. It was due to an increase in IL-6 level but a 
decrease in IL-10 level from 0 to 48 hours. The log ratios of IL-6 to IL-10 were 2.7, 
3.1，4.7, and the log ratios of IL-10 to TNF-a were 3.5, 3.2，and 2.8 at 0, 24, and 48 
hours, respectively. 
4.3 Discussion 
During infection, the host produces several proinflammatory cytokines that have 
been implicated as playing a critical role in the pathogenesis of the disease (Charles A 
1997). In this study, seven cytokines belonging to the proinflammatory and 
anti-inflammatory categories were studied. The proinflammatory cytokines included 
IL-2, IL-6, IFN-y and TNF-a, and the anti-inflammatory cytokines were IL-4 and 
IL-10. Our data demonstrated that these proinflammatory and anti-inflammatory 
cytokines were regulated even in preterm, very low birth weight infants. IL-5 is 
related to the development of allergy and the regulation of eosinophilia and remained 
largely unaffected in both infected and non-infected infants. On the contrary, the 
proinflammatory plasma IL-6 was markedly elevated in the infected group compared 
with the non-infected group, with up to 35, 6, and 6 fold at the time 0, 24 hours and 
48 hours, respectively (Table 4a). Similarly, the anti-inflammatory plasma IL-10 was 
increased in 22 fold in infected infants compared with non-infected infants at 0 hour 
— 
Chapter 4 ： Proinflammatory and anti-inflammatory cytokines 
and remained elevated 6 and 3 fold at 24 hours and 48 hours, respectively. These 
cytokine levels were decreased by 83% and 87% after 48 hours after successful 
antibiotic treatment. 
Although many researchers have investigated the immune pathways during 
infection, the interaction and the exact mechanism of proinflammatory and 
anti-inflammatory cytokines in response to sepsis remained a controversial subject. A 
recent study (van Dissel JT 1998) showed that the increase in anti-inflammatory 
cytokine profile was associated with mortality in the early stage of systemic infection. 
They found that febrile adult patients with a higher IL-10 to TNF-a ratio had an 
increased risk of mortality than those with a lower cytokine ratio. However, other 
studies (Gerard C 1993, Howard M 1993, van der Poll T 1995) showed that the 
exogenous administration of IL-10 could protect the excessive proinflammatory 
cytokine production and mortality rate. In our study, the results also showed a 
significant increase in IL-10 to TNF-a ratio in more severely infected infants at the 
onset of sepsis but the ratio fell markedly and began to normalize after 48 hours 
(Figure 4.1). This phenomenon demonstrated that the transiently elevated plasma 
IL-10 levels or IL-10 to TNF-a ratios might not indicate a poor prognosis, as all 
except one of our patients with DIC survived. Although IL-10 to TNF-a ratio of the 
_ 
Chapter 4 ： Proinflammatory and anti-inflammatory cytokines 
deceased patient declined after commencement of treatment, this ratio remained high 
at 48 hours (Log IL-10 to TNF-a ratio = 2.8). Taniguchi et al reported that the 
non-survivors of systemic inflammatory response syndrome (SIRS) had a higher IL6 
to IL-10 ratio compared with survivors (Taniguchi T 1999). Our results also 
demonstrated a significantly higher IL-6 to IL-10 ratio in patients with DIG compared 
with patient without DIG. The ratio remained at high level during 48 hours. This ratio 
was disproportionally increased in the deceased infant at the onset of sepsis and 
continued to increase even with commencement of antibiotic treatment. It was 
because the level of plasma IL-6 in the deceased patient was dramatically elevated 
from 1875 and 1855 pg/mL at 0 hour and 24 hours, to 5608 pg/mL at 48，but plasma 
IL-10 decreased steady from 122 pg/mL (0 hour) to 48 pg/mL (48 hours). This 
observation suggested that there was an exaggeration of proinflammatory cytokine 
activity accompanied by an inadequate anti-inflammatory cytokine compensation in 
an infant whose clinical condition had been overwhelmed by severe sepsis. 
The cytokine producing CD4+ helper cells are classified into Thl and Th2 cells 
on the basis of the cytokines they produced (Mosmann TR 1986，Kelso A 1995). Thl 
cells secrete high levels of IL-2, TNF-a, and IFN-y. These cytokines activates 
macrophages and promotes cell-mediated immune response against invasive 
— 
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intracellular pathogens. Th2 cells produce a variety of anti-inflammatory cytokines, 
including IL-4, IL-5, IL-6, IL-10 and IL-13. Th2 cytokines promote humoral immune 
response against extracellular pathogens. Mutual cross inhibition between Thl- (e.g. 
IFN-y) and Th2-type (IL-10) cytokines polarize functional Th cell response into 
cell-mediated or humoral immune response (Mosmann TR 1986). Van der Oill et al 
showed that IL-10 was up-regulated by circulating TNF-a (Van der Oill T 1994). 
Plasma cytokine IL-10 has the ability to suppress the synthesis of proinflammatory 
cytokines from T cells, leucocytes, and macrophages, and effectively down-regulates 
the proinflammatory response (Cassatella MA 1993, Fiorentino DF 1991). Marchant 
et al reported that in septic patients IL-10 concentrations were elevated and suggested 
that the intensity of the anti-inflammatory response could be related to the degree of 
monocyte or macrophage activation (Marchant A 1994). Derkx et al reported high 
concentrations of IL-10 during early meningococcal septic shock (Derkx B 1995). 
Doughty et al also reported that ILIO concentrations were higher in septic children 
than in non-septic children (Doughty LA 1996). IL-6 was also found to be a sensitive 
parameter for the early diagnosis of neonatal bacterial infection (Buck C 1994, Ng PC 
1997, Gonzalez BE 2003). The results of this study also showed a significant 
correlation between IL-6 and IL-10 or TNF-a in infected preterm infants and 
suggested that a balance of counter-regulatory immune mechanism is probably 
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operational in very early gestation.. 
In summary, it could be concluded that both plasma IL-6 and IL-10 might play a 
crucial role in balancing the beneficial and adverse effects of the cytokine cascade 
during systemic infection in preterm, VLBW infants. Our results suggested that the 
counter-regulation of immune response between proinflammatory cytokines and 
anti-inflammatory cytokines are probably developed and operational early in preterm, 
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Figure 4.1. Comparison of interleukin (IL) 10 / tumour necrosis factor (TNF)- a 
ratios between septic infants with and without disseminated intravascular 
coagulation (DIC). The ILlO/TNF-a ratios at 0 and 24 hours were significantly 
higher in infected infants with DIC (excluding the death case) than in those 
without. Double asterisks indicate a significant difference in the corresponding 
IL-lO/TNF-a ratio between the two groups with p < 0.01. Results are mean (SEM) 
_ 
Chapter 4 ： Proinflammatory and anti-inflammatory cytokines 
2.51 
一 Die 
2.0 • no Die 
幸 1.5i , ,L 
2 1.0 
3 丄 
1 .5 丁 —— 




-1.0 1 1 
0 24 48 
Time (hours) 
Figure 4.2. Comparison of interleukin(IL) 6/IL-lO ratios between septic infants 
with and without disseminated intravascular coagulation (DIC). The IL-6/IL-10 
ratio at 0’ 24’ and 48 hours were significantly higher in infected infants with DIC 
(excluding the death case) than in those without DIC. One asterisk indicates a 
significant difference in the corresponding IL-6/IL-10 ratio between the two 
groups with p < 0.05. Results are mean (SEM) 
— 
Chapter 5: General discussion and conclusions 
Chapter 5 
General Discussion and Conclusions 
— 
Chapter 5: General discussion and conclusions 
5.1 General Disscussion 
5.1-1 Cell surface markers 
An early clinical marker with high diagnostic sensitivity and specificity for 
late-onset neonatal sepsis in preterm, very low birth weight (VLBW) infants would be 
a valuable tool for therapeutic decision-making, and also to avoid the unnecessary use 
of antibiotics in patients without infection. In this study, we have evaluated four cell 
surface markers including two neutrophil surface markers (CD64 and CDl lb) and 
two lymphocyte markers (CD45RO and CD25). CD64 is normally expressed in very 
low levels by unstimulated neutrophils. It is markedly up-regulated upon the trigger of 
bacterial invasion (Fjaertoft G 1999), and has been demonstrated to be involved in the 
process of phagocytosis and intracellular killing of pathogens (de Haas M 1995; 
Sanchez-Mejorada G 1998). More importantly, neutrophils from preterm infants 
express CD64 during bacterial infections to the same degree as those from term 
infants, children and adults (Fjaertoft G 1999). After analyzing 127 suspected 
infection episodes with 37 having proven neonatal sepsis over a two-year period, 
neutrophil surface antigen CD64 is found to be the most promising diagnostic marker 
for determination of late-onset neonatal sepsis in preterm VLBW infants. It has high 
sensitivity, specificity, positive and negative predictive value ranging from 95% to 
97%, 86% to 90%, 80% and 93% to 99% respectively, during the three specific time 
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points (i.e. 0, 24, and 48 hours) of sepsis evaluation. 
On the other hand, combining other diagnostics markers such as plasma cytokine 
IL-6 and C-reactive protein (Ng PC et al 2002) with neutrophil CD64 further 
enhances the ability to diagnose localised bacterial infections, and improves the 
sensitivity and negative predictive value to 100%. It provides important information 
to clinicians for discontinuation of antibiotic treatment confidently in non-infected 
patients without waiting for the definitive microbiological culture results. The other 3 
cell surface antigens, however, were not considered to be useful markers for 
diagnosing nosocomial infection in preterm infants. 
To date, most reports on cell surface antigen expression use a semi-quantitative 
method of flow cytometric measurement (Weirich E 1998, Weinschenk NP 2000). 
This study provides an additional advantage of being able to quantify the number of 
antigens expressed on the cell surface, and therefore able to provide a numerical cut 
off value for determination of genuine neonatal sepsis. Such test can be readily 
performed on an ad hoc basis, and each test requires only a minimal volume of blood 
(0.05 ml of whole blood) that it is especially beneficial to newborn infants. 
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5.1-2 Infection markers with prognostic significance 
The results of our study suggest (Ng PC 2003) that the proinflammatory 
cytokines (IL-2, IL-6, IFN-y and TNF-a) and anti-inflammatory cytokines (IL-4 and 
IL-10) counter-regulatory mechanisms are probably operational very early in 
gestation. Further, septic infants with DIC show disproportional elevations of IL-10 
levels or IL-lO/TNF-a and 1L-6/IL-10 ratios. However, transient elevations of these 
levels and ratios do not necessarily indicate a poor outcome, as these indices drop 
precipitously following successful treatment. We speculate that key mediators such as 
IL-6, TNFa and IL-10 play a crucial role in balancing the risks and benefits of the 
inflammatory cascade during systemic infection. Recent advances in flow cytometric 
technology allow quantitative measurement of a large panel of inflammatory 
mediators with a minimal volume (0.05 mL plasma) of blood and would, therefore, be 
very suitable for assessing the pathophysiological process of infection in newborn 
infants. 
5.1-3 Limitations of infection markers in clinical applications 
Although some studies (Franz AR 1999, Weinschenk NP 2000) show their 
promising results for the diagnosis of neonatal sepsis, most diagnostic markers fail to 
meet the stringent demands required for clinical practice. Most research laboratories 
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tend to perform the analyses in batches, and this defeats the purpose of using them as 
'early ‘ warning markers. Unless the assay methods become automated (Franz AR 
1999, 200\),ad hoc measurement of these blood samples will not be cost-effective. 
In contrast, cell surface antigen expressions are usually measured on an individual 
basis, but these tests are expensive. The timing of specimen collection and different 
method of processing may also affect the cell surface antigen expression. 
For an infection marker to be useful as a routine clinical tool, high comparability 
and reproducibility across different laboratories is required. The heterogeneous 
methods of laboratory measurement, the wide variations in data analysis and in 
reporting results, have virtually excluded the possibility of performing a meaningful 
meta-analysis. Thus, it is often difficult to formulate a definitive opinion concerning 
the clinical usefulness of infection markers from the published reports. 
Despite the very high sensitivity and negative predictive value suggested in some 
diagnostic markers, most neonatal clinicians will be reluctant to withhold antibiotic 
treatment for a deteriorating infant at the onset of a suspected septic episode. This is 
because none of the current infection markers can consistently diagnose 100% of 
infected cases, and the consequence of misdiagnosing a potentially treatable but life 
m 
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threatening condition will be devastating and ethically unacceptable. Moreover, 
serious localized infections such as pneumonia, deep tissue abscess and cerebral 
ventriculitis, have been associated with normal levels of circulating markers (Ng PC 
1997, Ng PC 2000). 
5.2 Conclusions and future development 
5.2-1 Conclusions 
Useful diagnostic markers are important for the determination of neonatal sepsis. 
Plasma cytokine IL-6 and neutrophil CD64 are found to be 'early-sensitive ‘ markers 
of infection in our studies (Ng et al 1997, Ng et al 2002) whereas CRP is a 
'late-specific ‘ diagnostic test (Ng PC 1997). CD64 is probably one of the most useful 
infection markers for diagnosis of late onset nosocomial sepsis. Serial measurements 
of infection markers will certainly improve the sensitivity of diagnosing late-onset 
neonatal sepsis. Combining early-sensitive markers with a late-specific test will 
further enhance the diagnostic accuracy of the infected cases. In addition, 
proinflammatory and anti-inflammatory cytokines such as IL-6, TNF-a and IL-10 
play a significant role in the manifestation and out-come of septicemic infection. 
5.2-2 The future development 
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The development for an 'ideal' diagnostic marker or a set of markers for 
diagnosis of neonatal sepsis will definitely continue. Recently reports (James C 1999; 
Shixin Qin 1998, Hsu CD 1998, Helena Martin 2001) indicate that new chemokines, 
antimicrobial peptides, acute phase reactants and cell surface antigens such as 
epithelial neutrophil activating peptide-8 (ENA-78), growth-related oncogene-a 
(GRO-a) (Sullivan SE 2002), human (3-defensin 1 and 2, cathelicidin 
LL-37/hCAP-18 (Schaller-Bals S 2002), calprotectin (Carroll D 2003), soluble CD14 
(Berner R 2002) and other new markers are currently under investigation. The 
advance in flow cytometric technology enable quantitation of inflammatory mediators 
or cell surface antigens, and demands only a minimal volume of blood that will be 
most useful for identifying the appropriate cytokines or cell surface markers for the 
diagnosis of neonatal sepsis. Polymerase chain reaction (PCR) is another tool for 
detection of the genetic materials of pathogens in blood, sterile body fluids and tissue 
samples. This technique is particularly useful in identifying the exact type of pathogen 
responsible for the infection. However, further improvement would be needed to 
avoid the currently high false positive rate in the detection of bacteria residues. At 
present, none of the current diagnostic markers are sensitive or specific enough for 
allowing clinicians to withhold antibiotic in an ill infant with suspected clinical sepsis. 
Thus, more research work is required in searching for an 'ideal' marker of infection 
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